JP Morgan has reiterated its 'Overweight' rating on Xometry and increased its price target from $120 to $140. This adjustment implies a potential upside of 25.8% from the closing price, signaling continued analyst confidence in the company's future performance.
JP Morgan has maintained its 'Overweight' rating on Xometry and raised its price target from $120 to $140, representing a 16.7% increase. This positive analyst action suggests a potential upside of 25.8% for Xometry based on its November 3, 2026 closing price. This is significant for Xometry as it indicates strong institutional confidence and could attract further investor interest, potentially driving the stock price higher in the short term. For traders, this presents an opportunity to capitalize on the positive sentiment, though long-term performance will depend on Xometry's ability to meet or exceed the expectations embedded in this new valuation.